Petroleo Brasileiro S.A. (XPBRA)
Madrid Exchange · Spain · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 10.10 |
|---|---|
| 52-week range | 4.80 – 10.43 |
| Return, 1 month / 3 months | +22.5% / +39.5% |
| Return, 1 year / 3 years | +123.7% / +122.1% |
| Trend | Uptrend |
| RSI (14) | 79 |
| Volatility (1 year) | 37.4% |
| Worst drawdown (1 year) | -21.0% |
| Average daily value traded | 0.24M EUR |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Petroleo Brasileiro S.A., commonly called Petrobras, is an integrated energy company based in Brazil. It explores for and produces crude oil and natural gas, largely from deepwater offshore fields, and operates refineries that turn crude into fuels such as gasoline, diesel and aviation fuel. It also produces petrochemicals, lubricants and biofuels, and distributes and markets fuels and natural gas to industrial, commercial and transport customers in Brazil and abroad.
On this site Petroleo Brasileiro S.A. appears as a stock on the Madrid Exchange (Spain), code XPBRA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Petroleo Brasileiro S.A. (XPBRA) trades on the Madrid Exchange in Spain. It last closed at EUR 10.10 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 23 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 123.7% and over the last three months it rose 39.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 96 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 46.3% | ||
| From 52-week high | 0.0% | ||
| Momentum | 98 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 39.5% | ||
| 6-month return | 34.3% | ||
| 12-month return, skipping the last month | 82.6% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.0% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.24M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | +22.5% |
| 3 months | +39.5% |
| 6 months | +34.3% |
| 1 year | +123.7% |
| 3 years | +122.1% |
| 5 years | +1,650.0% |
Signals
| 50-day / 200-day average | 8.26 / 6.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | BRL 0.2359 |
| 29 May 2026 | BRL 0.1227 |
| 23 Apr 2026 | BRL 0.1160 |
| 19 Dec 2025 | BRL 0.1666 |
| 20 Aug 2025 | BRL 0.1176 |
| 30 May 2025 | BRL 0.1591 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.